Your browser doesn't support javascript.
loading
A case report and literature review of metastatic prostate cancer with primary hyperfibrinolysis as the first presentation / 中国综合临床
Clinical Medicine of China ; (12): 471-474, 2023.
Article in Zh | WPRIM | ID: wpr-1026685
Responsible library: WPRO
ABSTRACT
We reported a rare case with metastatic prostate cancer complicated with hemorrhagic syndrome caused byprimary hyperfibrinolysis.The correct diagnosis of bleeding disorders is a prerequisite for choosing the correct treatment.Tranexamic acid can be used as the preferred treatment for patients with bleeding caused by primary hyperfibrinolysis. In this case, the combination of antifibrinolytics and antiandrogen therapy effectively controlled the severe bleeding symptoms caused by primary hyperfibrinolysis in metastatic prostate cancer. Appropriate treatment after early diagnosis is essential to prevent bleeding and improve prognosis.
Key words
Full text: 1 Index: WPRIM Language: Zh Journal: Clinical Medicine of China Year: 2023 Type: Article
Full text: 1 Index: WPRIM Language: Zh Journal: Clinical Medicine of China Year: 2023 Type: Article